ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 3.010
-0.040 (-1.31%)
May 28, 2026, 4:08 PM HKT
HKG:1541 Market Cap
HKG:1541 has a market cap or net worth of 1.32 billion as of May 28, 2026. Its market cap has decreased by -51.26% in one year.
Market Cap
1.32B
Enterprise Value
437.76M
Revenue
171.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.01
Market Cap Chart
Since September 5, 2023, HKG:1541's market cap has decreased from 7.29B to 1.32B, a decrease of -81.94%. That is a compound annual growth rate of -46.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 1.32B | -47.68% |
| Dec 31, 2025 | 2.52B | 19.70% |
| Dec 31, 2024 | 2.10B | -81.21% |
| Dec 29, 2023 | 11.19B | 53.55% |
| Sep 5, 2023 | 7.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SinoMab BioScience | 1.82B |
| Frontage Holdings | 1.66B |
| Mabpharm | 1.65B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.49B |
| Beijing Biostar Pharmaceuticals | 1.48B |
| Zhaoke Ophthalmology | 1.40B |
| Cutia Therapeutics | 1.34B |
| Kintor Pharmaceutical | 1.14B |